Stock Events

Stock Events

Celularity 

$0.8000
34
+$0.03+4.3% Friday 19:59
+$0.03+4.31%Friday 23:04After hours

Statistics

Day High
0.8
Day Low
0.8
52W High
4.01
52W Low
0.56
Volume
307
Avg. Volume
-
Mkt Cap
23.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-1.5
-1.25
-1
-0.75
Expected EPS
N/A
Actual EPS
N/A

Financials

-345.45%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
26.55MRevenue
-91.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELU. It's not an investment recommendation.
NVIDIA
11
NVDA
Alphabet
11
GOOGL
Tesla
10
TSLA
Amazon
10
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is involved in gene editing, a technology that could compete with Celularity's cellular therapies for various diseases.
Fate Therapeutics
FATE
Mkt Cap307.94M
Fate Therapeutics is developing programmed cellular immunotherapies, competing in the cell therapy space with Celularity.
Novartis
NVS
Mkt Cap286.78B
Novartis offers CAR-T cell therapies, which are a form of cellular therapy competing with Celularity's products.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cellular therapy space, particularly in cancer treatment.
Allogene Therapeutics
ALLO
Mkt Cap708.26M
Allogene Therapeutics is focused on allogeneic CAR-T therapies, which are in direct competition with Celularity's approach to cancer treatment.

About

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Show more...
CEO
Robert Joseph Hariri
Employees
115
Country
United States
ISIN
US1511902041

Listings

XNAS
US
CELU
BOATS
BOATS
CELU.BOATS

0 Comments

Share your thoughts

FAQ

What is Celularity stock price today?▼
The current price of CELU is $0.80 USD — it has increased by +4.3% in the past 24 hours. Watch Celularity stock price performance more closely on the chart.
What is Celularity stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Celularity stocks are traded under the ticker CELU.
Is Celularity stock price growing?▼
CELU stock has risen by +14.98% compared to the previous week, the month change is a +2.56% rise, over the last year Celularity has showed a -78.89% decrease.
What is Celularity market cap?▼
Today Celularity has the market capitalization of 23.16M
When is the next Celularity earnings date?▼
Celularity is going to release the next earnings report on November 13, 2026.
What is Celularity revenue for the last year?▼
Celularity revenue for the last year amounts to 26.55M USD.
What is Celularity net income for the last year?▼
CELU net income for the last year is -91.72M USD.
How many employees does Celularity have?▼
As of August 22, 2026, the company has 115 employees.
In which sector is Celularity located?▼
Celularity operates in the Health & Wellness sector.
When did Celularity complete a stock split?▼
The last stock split for Celularity was on February 29, 2024 with a ratio of 1:10.
Where is Celularity headquartered?▼
Celularity is headquartered in FLORHAM PARK, United States.